Healthpeak Properties (DOC) Q3 2026 Earnings
FFO as Adjusted excludes $8.379 million of transaction, merger, and restructuring-related costs (including senior housing operator transition costs); GAAP diluted EPS was $0.02
How Did DOC Stock React to Q3 2026 Earnings?
Did DOC Beat Earnings? Q3 2026 Results
Healthpeak Properties delivered a mixed but strategically eventful third quarter of 2026, with adjusted FFO per share of $0.44 on revenue of $820.89 million, as robust senior housing momentum offset softness in its lab segment. The standout driver was Janus Living, Healthpeak's majority-owned senior housing REIT, which posted revenue of $268.00 million, up 78% year over year, and Adjusted EBITDAre of $105.00 million, up 101%, fueled by $1.75 billion in acquisitions closed during the quarter. Same-store senior housing NOI surged 25.9%, while the lab segment slipped 0.7% and outpatient medical grew a steady 3.1%. On a GAAP basis, Healthpeak swung to a profit of $0.02 per diluted share from a loss of $0.17 a year ago, when results were weighed down by $175.83 million in impairment charges on lab joint ventures. Looking ahead, management raised its full-year FFO as Adjusted guidance to $1.76 to $1.78 per share while trimming its GAAP EPS outlook to $0.39 to $0.41, attributing the latter reduction to depreciation tied to Janus Living's acquisition activity.
- Total Same-Store Adjusted NOI growth of 3.6% year over year
- Senior Housing same-store Adjusted NOI up 25.9%; Outpatient Medical up 3.1%; Lab down 0.7%
- Janus Living revenue up 78% to $268 million and Adjusted EBITDAre up 101% to $105 million
- Outpatient Medical leasing of 846,000 sq ft in Q3 (3.2 million sq ft YTD)
- Lab leasing of 480,000 sq ft in Q3 (1 million sq ft YTD); Lab occupancy up 130 bps sequentially and 270 bps since year-end 2025
- $1.75 billion of senior housing acquisitions closed by Janus Living during Q3
What Is Healthpeak Properties's Outlook?
Healthpeak raised its full-year 2026 diluted FFO as Adjusted guidance to $1.76–$1.78 per share (from $1.73–$1.77), a $0.02 midpoint increase. It raised Total Same-Store Cash (Adjusted) NOI growth guidance to 0.5%–2.0% (from 0%–1.5%). It lowered diluted EPS guidance to $0.39–$0.41 (from $0.48–$0.52), primarily due to depreciation and amortization from Janus Living's senior housing acquisitions, which has no impact on FFO as Adjusted. Diluted Nareit FFO is guided at $1.72–$1.74. Two pending life science acquisitions are expected to close in Q4 2026 or early 2027.
DOC YoY Financials
DOC Revenue by Segment
When Does Healthpeak Properties Report Next?
Figures from SEC filings and company reports. Not investment advice.